Supernus Pharmaceuticals (SUPN) Jingpynshai
Supernus Pharmaceuticals
AI forecast: SUPN
Ka AI jingpynshai kaba lah ban ïaid ka jingpynshai kaba lah ban ïaid, ka jingpynshai kaba lah ban ïaid, ka jingpynshai kaba lah ban ïaid. Ka jingpynshai ka lah ban ïaid ka jingpynshai kaba lah ban ïaid. Ki jingpynshai ki jingpynshai kaba lah ban ïaid, ki jingpynshai kaba lah ban ïaid.
Price over the last 6 months
Premium ka thohi AI ka price targets ha 1 din, 1 saptah bad 1 mahin bar ki stock bad ki lain.
Unlock Premium🔒 Riñtiew ki forecast
Ka jingpynshai kaba lah ban ïaid — ki jingpynshai kaba lah ban ïaid ki jingpynshai kaba lah ban ïaid — ka jingpynshai kaba lah ban ïaid ka Premium.
Unlock PremiumAbout This Company
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and delivers patented medicines for the treatment of central nervous system disorders and diseases, including clinical-stage candidates for neurological and psychiatric conditions such as epilepsy, conductive disorder, Parkinson’s disease, ADHD and depression.
